🕵️ Adial Pharmaceuticals, Inc. ($ADIL)
SEC insider & ownership activity, last 12 months · CIK 1513525 · every row links its SEC filing
Over the last 12 months insiders bought $206K with no open-market selling against it. Coastlands Capital LP bought $106K (Jun–Jul). No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
2 buyers, $206K (6 lots) · 0 sellers, $0 (0 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Coastlands Capital LP | 5 | $106K | 0 | – | Jul 16, 2026 |
| Wendy B. Young | 1 | $100K | 0 | – | Jun 12, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Coastlands Capital LP | 14.2% | 13G | Jul 1, 2026 | filing ↗ | |
| Coastlands Capital Partners LP | 14.2% | 13G | Jul 1, 2026 | filing ↗ | |
| Coastlands Capital GP LLC | 14.2% | 13G | Jul 1, 2026 | filing ↗ | |
| Coastlands Capital LLC | 14.2% | 13G | Jul 1, 2026 | filing ↗ | |
| Matthew D. Perry | 14.2% | 13G | Jul 1, 2026 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Material agreement (1.01) | Jun 11, 2026 | filing ↗ |
| Acquisition or disposition (2.01) | Jun 11, 2026 | filing ↗ |
| New financial obligation (2.03) | Jun 11, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Jun 11, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jun 11, 2026 | filing ↗ |
| Charter/bylaw changes (5.03) | Jun 11, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jun 11, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 11, 2026 | filing ↗ |
| Earnings (2.02) | May 11, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 11, 2026 | filing ↗ |
| Officer/director changes (5.02) | Apr 7, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 7, 2026 | filing ↗ |
| Earnings (2.02) | Mar 6, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 6, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Feb 26, 2026 | filing ↗ |
| Other events (8.01) | Feb 26, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 26, 2026 | filing ↗ |
| Other events (8.01) | Feb 23, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 23, 2026 | filing ↗ |
| Material Modifications to Rights of Security Holders (3.03) | Feb 3, 2026 | filing ↗ |
| Charter/bylaw changes (5.03) | Feb 3, 2026 | filing ↗ |
| Other events (8.01) | Feb 3, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 3, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jan 5, 2026 | filing ↗ |
| Material agreement (1.01) | Nov 25, 2025 | filing ↗ |
| Unregistered equity sale (3.02) | Nov 25, 2025 | filing ↗ |
| Other events (8.01) | Nov 25, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 25, 2025 | filing ↗ |
| Earnings (2.02) | Nov 14, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 14, 2025 | filing ↗ |